Premium
Antihypertensive effect of diacetolol in essential hypertension.
Author(s) -
Thibonnier M,
Flabeau C,
Thouvenin M,
Roux A,
Flouvat B,
Pasquier P,
Menard J
Publication year - 1982
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1982.tb01417.x
Subject(s) - acebutolol , blood pressure , plasma renin activity , medicine , essential hypertension , heart rate , metabolite , pharmacology , ingestion , antihypertensive drug , pharmacokinetics , endocrinology , renin–angiotensin system
1 Diacetolol is the N‐acetylated metabolite of acebutolol and possesses beta‐adrenergic receptor blocking properties. 2 Its antihypertensive action was assessed in accordance with a double‐blind randomised cross‐ over scheme in 17 patients with moderate essential hypertension previously well controlled with acebutolol. 3 Significant reductions in lying mean arterial blood pressure were observed with daily doses of 200 mg (‐ 9%), 400 mg (‐ 10%) and 800 mg (‐ 14%), and were associated with significant decreases in heart rate and plasma renin activity. 4 The diacetolol mean plasma level measured 8 to 10 h after drug ingestion was proportional to the dose (207 +/‐ 27, 394 +/‐ 63 and 823 +/‐ 135 ng/ml for respectively 200, 400 and 800 mg/day).